Last updated on September 2016

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma


Brief description of study

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Detailed Study Description

The purpose of the study is to assess the efficacy, safety, and tolerability when combining pembrolizumab with epacadostat or placebo in subjects with unresectable or metastatic melanoma.

Clinical Study Identifier: TX145132

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.